Response to:'Rational use of tocilizumab in COVID-19'by Jain and Sharma

N Potere, M Di Nisio, D Cibelli, R Scurti… - Annals of the …, 2022 - ard.bmj.com
We thank Jain and Sharma 1 for their interest in our recent report on interleukin-6 (IL-6)
receptor blockade with subcutaneous tocilizumab (324 mg, given in two concomitant 162 mg …
相关文章

[引用][C] Response to:'Rational use of tocilizumab in COVID-19'by Jain and Sharma

N Potere, M Di Nisio, D Cibelli… - Annals of the …, 2022 - pubmed.ncbi.nlm.nih.gov
Response to: 'Rational use of tocilizumab in COVID-19' by Jain and Sharma Response to: 'Rational
use of tocilizumab in COVID-19' by Jain and Sharma Ann Rheum Dis. 2022 Nov;81(11):e215 …

Response to:'Rational use of tocilizumab in COVID-19'by Jain and Sharma

N Potere, M Di Nisio, D Cibelli, R Scurti… - Annals of the …, 2022 - search.proquest.com
Abstract We thank Jain and Sharma1 for their interest in our recent report on interleukin-6 (IL-
6) receptor blockade with subcutaneous tocilizumab (324 mg, given in two concomitant 162 …
[PDF] archive.org

[PDF][PDF] Response to:'Rational use of tocilizumab in COVID-19'by Jain and Sharma

N Potere, M Di Nisio, D Cibelli, R Scurti, A Frattari… - 2020 - scholar.archive.org
We thank Jain and Sharma 1 for their interest in our recent report on interleukin-6 (IL-6)
receptor blockade with subcutaneous tocilizumab (324 mg, given in two concomitant 162 mg …
[PDF] bmj.com

[PDF][PDF] Response to:'Rational use of tocilizumab in COVID-19'by Jain and Sharma

N Potere, M Di Nisio, D Cibelli, R Scurti… - Annals of the …, 2020 - ard.bmj.com
We thank Jain and Sharma 1 for their interest in our recent report on interleukin-6 (IL-6)
receptor blockade with subcutaneous tocilizumab (324 mg, given in two concomitant 162 mg …

[引用][C] Response to:'Rational use of tocilizumab in COVID-19'by Jain and Sharma

N Potere, M di Nisio, D Cibelli… - Annals of the …, 2020 - researchinformation.amsterdamumc …
Response to: 'Rational use of tocilizumab in COVID-19' by Jain and Sharma — Amsterdam
UMC research portal Skip to main navigation Skip to search Skip to main content Amsterdam …

[引用][C] Response to:'Rational use of tocilizumab in COVID-19'by Jain and Sharma.

N Potere, M Di Nisio, D Cibelli, R Scurti… - Annals of the …, 2020 - europepmc.org
This is a comment on" Rational use of tocilizumab in COVID-19." Ann Rheum Dis. 2022 Nov;
81 (11): e213. This is a comment on" Interleukin-6 receptor blockade with subcutaneous …